Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer

作者: Hans-Stefan Hofmann , Andreas Simm , Andreas Hammer , Rolf-Edgar Silber , Babett Bartling

DOI: 10.1007/S00432-002-0364-Z

关键词: PathologyGene expressionCancer researchSurvivinApoptosisGene productAdenocarcinomaCarcinomaBiologyXIAPCarcinogenesisOncologyGeneral Medicine

摘要: Abstract Purpose. Apoptotic cell death contributes to the regulation of tumour regression but can be prevented by proteins IAP family. Although survivin identified as tumour-specific gene product, role other members family is mainly unclear in non-small lung cancer (NSCLC). Therefore, we hypothesise that hIAP-1, hIAP-2, and XIAP are associated with carcinogenesis, too. Methods. To define expression levels, samples from 34 NSCLC patients adenocarcinoma (16) squamous carcinoma (18) were included. Analyses performed standardised RT-PCR immunoblotting. Paired non-tumour tissues served controls. All showed a strong mRNA up-regulation compared Results. Investigations revealed an overall increase (median: 1,083 vs 605 rel. U; P =0.02). In contrast, hIAP-2 was nearly identical all control samples. Furthermore, elevated hIAP-1 especially 8.58 3.44 <0.01). Using median 50% determined tumours cut-off point, 11/16 only 6/18 elevation mRNA. This could observed low TMN adenocarcinomas (7/9 I, increase: +289% 2/5 III–IV, +44.6%). An enhanced respective confirmed on protein level immunoblot analyses. Conclusions. Our results indicate involvement anti-apoptotic pathogenesis NSCLC, while preferentially seems play important low-stage adenocarcinoma.

参考文章(25)
J C Reed, Mechanisms of Bcl-2 family protein function and dysfunction in health and disease. Behring Institute Mitteilungen. pp. 72- 100 ,(1996)
Martin Holcik, Charles Lefebvre, Chiaoli Yeh, Terry Chow, Robert G. Korneluk, A new internal-ribosome-entry-site motif potentiates XIAP- mediated cytoprotection Nature Cell Biology. ,vol. 1, pp. 190- 192 ,(1999) , 10.1038/11109
C. S. Duckett, V. E. Nava, R. W. Gedrich, R. J. Clem, J. L. Van Dongen, M. C. Gilfillan, H. Shiels, J. M. Hardwick, C. B. Thompson, A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. The EMBO Journal. ,vol. 15, pp. 2685- 2694 ,(1996) , 10.1002/J.1460-2075.1996.TB00629.X
Quinn L. Deveraux, Ryosuke Takahashi, Guy S. Salvesen, John C. Reed, X-linked IAP is a direct inhibitor of cell-death proteases Nature. ,vol. 388, pp. 300- 304 ,(1997) , 10.1038/40901
Knolle J, Hofmann Hs, Neef H, The adenosquamous lung carcinoma: clinical and pathological characteristics. Journal of Cardiovascular Surgery. ,vol. 35, pp. 543- 547 ,(1994)
D. C. Altieri, C. Adida, P. L. Crotty, J. Diebold, D. Berrebi, J. McGrath, Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. American Journal of Pathology. ,vol. 152, pp. 43- 49 ,(1998)
Mariano Monzó, Rafael Rosell, Enriqueta Felip, Julio Astudillo, José Javier Sánchez, José Maestre, Cristina Martín, Albert Font, Agustí Barnadas, Albert Abad, A Novel Anti-Apoptosis Gene: Re-expression of Survivin Messenger RNA as a Prognosis Marker in Non–Small-Cell Lung Cancers Journal of Clinical Oncology. ,vol. 17, pp. 2100- 2100 ,(1999) , 10.1200/JCO.1999.17.7.2100
Colette Adida, Dominique Berrebi, Michael Peuchmaur, Miguel Reyes-Mugica, Dario C Altieri, Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. The Lancet. ,vol. 351, pp. 882- 883 ,(1998) , 10.1016/S0140-6736(05)70294-4
Joji Kato, Yoshiyuki Kuwabara, Masami Mitani, Noriyuki Shinoda, Atsushi Sato, Tatsuya Toyama, Akira Mitsui, Tadashi Nishiwaki, Satoru Moriyama, Junzo Kudo, Yoshitaka Fujii, Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. International Journal of Cancer. ,vol. 95, pp. 92- 95 ,(2001) , 10.1002/1097-0215(20010320)95:2<92::AID-IJC1016>3.0.CO;2-9